← Open Payments lookup

MELISSA RANZER: Open Payments

NPI 1912668120 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,683 in 76 payments from 15 companies in 2025. Trend: 2023 $1,376 · 2024 $1,463 · 2025 $1,683

Food & beverage: $1,683
CompanyPaymentsAmount
ABBVIE INC.28$421
GENZYME CORPORATION6$220
Ardelyx, Inc.14$188
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$180
Gilead Sciences, Inc.3$152
Celltrion USA Inc.1$123
Janssen Biotech, Inc.4$97
Regeneron Healthcare Solutions, Inc.5$95
Lilly USA, LLC3$55
Takeda Pharmaceuticals U.S.A., Inc.3$46

Products named: DUPIXENT, RINVOQ, IBSRELA, XIFAXAN, ZYMFENTRA, TREMFYA, OMVOH, MAVYRET.

Industry payments across NJ — which companies pay providers there.